CDC Relaxes Safety Guidance for Fully Vaccinated People
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
COVID Update May 21, 2021
COVID Update May 21, 2021 The US Centers for Disease Control and Prevention announced on Thursday May 13 that fully vaccinated people can go without masks in most circumstances. The new guidance was based on analysis of a new study that found that real-life use of the Moderna and Pfizer vaccines provided 94% protection for over 4,000 front-line health care workers immunized at the beginning of the vaccine rollout who had weekly COVID testing following vaccination. A single dose provided 82% protection, the CDC-led team reported in the agency's weekly report, the MMWR. The new study also showed that fully vaccinated people are unlikely to develop asymptomatic infection and unknowingly shed virus, because even if infected, they have a very low viral load. This corroborates the findings of three major studies that have shown that fully vaccinated people are not likely to test positive for coronavirus, which indicates they are not carrying it in their bodies, whether they have symptoms or not. A similar study from Israel also found vaccinated people who got infected had a lower viral load -- fourfold lower than unvaccinated people. The new CDC guidance states that vaccinated individuals can in general safely remove their masks in large and small groups, indoors and out. However, it was recommended that masks continue to be worn on public transportation (including trains, buses, airplanes), and in homeless shelters and correctional facilities. The new guidance does not apply to health care settings. Concern was immediately raised regarding increased risk to the unvaccinated, including children under 12 and individuals who are immunocompromised in whom the vaccine may not be effective; the fact that the new guidance relies on unvaccinated individuals continuing to mask and distance, which may not occur; and the known presence in the U.S. -
The Four Horsemen of the Restaurant Apocalypse?
The Four Horsemen of the Restaurant Apocalypse? How lessons from the travel industry’s response to online travel agencies may enable restaurants to survive (and hopefully thrive) in a delivery-heavy future. by Zach Goldstein, CEO and Founder, Thanx The Original Mel’s diner is a Northern California legend. Now at 22 locations, the classic drive-up service is long-gone, just one of many necessary adaptations for a restaurant that celebrated its 70-year anniversary two years ago. The latest evolution may be most challenging yet. “In our first two years on the delivery platforms, revenue went up 20% year-over-year. It was the largest top-line growth we’ve experienced in two decades,” said Tony Bendana, restaurant industry veteran and current Chief Operating Officer of The Original Mel’s which is listed in four third-party delivery apps today — Doordash, Uber Eats, Grubhub, and Postmates. “But when we looked at how much profit we were making, it hadn’t moved.” Tony Bendana, COO at The Original Mel’s What follows is an in-depth study of the massive disruption facing restaurants today, broken into the following sections: Restaurants Are Digitizing 04 More than $200B in restaurants sales will come through digital channels (including third-party marketplaces) by 2022 The Question of Incrementality 05 Because of high take-rates, many restaurants are questioning whether delivery marketplaces are friend or foe We’ve Seen This Story Before: Hotels and Online Travel Agencies 08 OTAs grew rapidly and ultimately stole share from hotels themselves The -
Hiv Prevention Drug: Billions in Corporate Profits After Millions in Taxpayer Investments
HIV PREVENTION DRUG: BILLIONS IN CORPORATE PROFITS AFTER MILLIONS IN TAXPAYER INVESTMENTS HEARING BEFORE THE COMMITTEE ON OVERSIGHT AND REFORM HOUSE OF REPRESENTATIVES ONE HUNDRED SIXTEENTH CONGRESS FIRST SESSION MAY 16, 2019 Serial No. 116–24 Printed for the use of the Committee on Oversight and Reform ( Available on: http://www.govinfo.gov http://www.oversight.house.gov http://www.docs.house.gov U.S. GOVERNMENT PUBLISHING OFFICE 36–660 PDF WASHINGTON : 2019 COMMITTEE ON OVERSIGHT AND REFORM ELIJAH E. CUMMINGS, Maryland, Chairman CAROLYN B. MALONEY, New York JIM JORDAN, Ohio, Ranking Minority Member ELEANOR HOLMES NORTON, District of JUSTIN AMASH, Michigan Columbia PAUL A. GOSAR, Arizona WM. LACY CLAY, Missouri VIRGINIA FOXX, North Carolina STEPHEN F. LYNCH, Massachusetts THOMAS MASSIE, Kentucky JIM COOPER, Tennessee MARK MEADOWS, North Carolina GERALD E. CONNOLLY, Virginia JODY B. HICE, Georgia RAJA KRISHNAMOORTHI, Illinois GLENN GROTHMAN, Wisconsin JAMIE RASKIN, Maryland JAMES COMER, Kentucky HARLEY ROUDA, California MICHAEL CLOUD, Texas KATIE HILL, California BOB GIBBS, Ohio DEBBIE WASSERMAN SCHULTZ, Florida RALPH NORMAN, South Carolina JOHN P. SARBANES, Maryland CLAY HIGGINS, Louisiana PETER WELCH, Vermont CHIP ROY, Texas JACKIE SPEIER, California CAROL D. MILLER, West Virginia ROBIN L. KELLY, Illinois MARK E. GREEN, Tennessee MARK DESAULNIER, California KELLY ARMSTRONG, North Dakota BRENDA L. LAWRENCE, Michigan W. GREGORY STEUBE, Florida STACEY E. PLASKETT, Virgin Islands RO KHANNA, California JIMMY GOMEZ, California ALEXANDRIA OCASIO-CORTEZ, New York AYANNA PRESSLEY, Massachusetts RASHIDA TLAIB, Michigan DAVID RAPALLO, Staff Director ALI GOLDEN, Chief Health Counsel ELISA LANIER, Director of Operations and Chief Clerk CHRISTOPHER HIXON, Minority Chief of Staff CONTACT NUMBER: 202-225-5051 (II) CONTENTS Page Hearing held on May 16, 2019 .............................................................................. -
Response: Just Eat Takeaway.Com N. V
NON- CONFIDENTIAL JUST EAT TAKEAWAY.COM Submission to the CMA in response to its request for views on its Provisional Findings in relation to the Amazon/Deliveroo merger inquiry 1 INTRODUCTION AND BACKGROUND 1. In line with the Notice of provisional findings made under Rule 11.3 of the Competition and Markets Authority ("CMA") Rules of Procedure published on the CMA website, Just Eat Takeaway.com N.V. ("JETA") submits its views on the provisional findings of the CMA dated 16 April 2020 (the "Provisional Findings") regarding the anticipated acquisition by Amazon.com BV Investment Holding LLC, a wholly-owned subsidiary of Amazon.com, Inc. ("Amazon") of certain rights and minority shareholding of Roofoods Ltd ("Deliveroo") (the "Transaction"). 2. In the Provisional Findings, the CMA has concluded that the Transaction would not be expected to result in a substantial lessening of competition ("SLC") in either the market for online restaurant platforms or the market for online convenience groceries ("OCG")1 on the basis that, as a result of the Coronavirus ("COVID-19") crisis, Deliveroo is likely to exit the market unless it receives the additional funding available through the Transaction. The CMA has also provisionally found that no less anti-competitive investors were available. 3. JETA considers that this is an unprecedented decision by the CMA and questions whether it is appropriate in the current market circumstances. In its Phase 1 Decision, dated 11 December 20192, the CMA found that the Transaction gives rise to a realistic prospect of an SLC as a result of horizontal effects in the supply of food platforms and OCG in the UK. -
IAS 2009: Conference Report
July-August 2009 WWW.IAVIREPORT.ORG | VOLUME 13, NUMBER 4 IAS 2009: Conference Report Challenge Models Characterizing and optimizing viral challenge models for vaccine research EDITOR’S LETTER What if there were magic pills that could effectively treat HIV infection, prevent HIV-infected indi- viduals from transmitting the virus to others, reduce prevalence of tuberculosis, and perhaps even protect uninfected individuals from acquiring HIV? Oh wait, maybe there are. They’re called antiretrovirals (ARVs), and they have revolutionized the treatment of HIV infection. So far, the road to developing biomedical interventions to prevent HIV infection has been a bit rockier. In his talk at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Pre- vention, held recently in Cape Town, South Africa (see Everything from Cause to Cure for our report on the conference), Ronald Gray of Johns Hopkins University noted that of 29 trials evaluating the efficacy of different biomedical HIV prevention strategies, only four have shown significant success, and five have wshown possible harm. Until an effective vaccine or other HIV prevention strategy is developed, ARVs are being billed as one of the greatest hopes for controlling the global spread of HIV. One ARV-based approach to prevention is getting more HIV infected individuals on therapy. Evidence is accumulating that starting ARV treatment earlier in the course of HIV infection is beneficial. For prevention, the idea is that therapy, which efficiently and rapidly reduces viral load, could prevent those people already infected from transmitting HIV to others. This serves as the basis for the so-called test and treat strategy, which is explored in this issue (see Test and Treat on Trial) . -
United States District Court Western District of Louisiana Lake Charles Division
UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAKE CHARLES DIVISION ) __________, Individually and on Behalf ) of all Others Similarly Situated, ) ) CIVIL ACTION NO. ________ Plaintiff, ) ) vs. ) CLASS ACTION COMPLAINT ) FOR VIOLATIONS OF ) CHRISTOPHER MEAUX, DAVID FEDERAL SECURITIES LAWS ) PRINGLE, JEFF YURECKO, TILMAN J. ) FERTITTA, RICHARD HANDLER, WAITR ) HOLDINGS, INC. f/k/a LANDCADIA ) HOLDINGS, INC., JEFFERIES FINANCIAL ) GROUP, INC., and JEFFERIES, LLC, ) JURY TRIAL DEMANDED Defendants. ) ) This action is brought as a class action by Plaintiff on behalf of himself and all others similarly situated against Waitr Holdings, Inc. (“Waitr” or the “Company”) and certain officers and directors and other individuals and entities associated with the Company for their violations of Sections 11, 12 and 15 of the 1933 Securities Act, 15 U.S.C. §§ 77a, et seq. (the “Securities Act”), and/or Sections 10(b), 14(a) and 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. §§ 78j(b) and 78t(a), (the “Exchange Act”) and Rule 10b-5 promulgated thereunder by the U.S. Securities Exchange Commission (the “SEC”) (17 C.F.R. § 240.10b-5), (A) in connection with Old-Waitr’s (defined below) going public transaction and business combination on November 15, 2018 with Landcadia Holdings, Inc. (“Landcadia”) (the “Going Public Transaction”), and the follow-on secondary offering on May 16, 2019 (the “Secondary Offering”) of Waitr securities (the “Negligence” and/or “Strict Liability” claims), and (B) for making materially false and misleading statements that were published into the market from May 17, 2018 to August 8, 2019 ( the “Class Period”), that Defendants knew and/or recklessly disregarded were materially false and misleading when made and/or that omitted information necessary to make Defendants’ statements, in light of such omissions, true, accurate and reliable. -
Global Equity Fund Description Plan 3S DCP & JRA MICROSOFT CORP
Global Equity Fund June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA MICROSOFT CORP 2.5289% 2.5289% APPLE INC 2.4756% 2.4756% AMAZON COM INC 1.9411% 1.9411% FACEBOOK CLASS A INC 0.9048% 0.9048% ALPHABET INC CLASS A 0.7033% 0.7033% ALPHABET INC CLASS C 0.6978% 0.6978% ALIBABA GROUP HOLDING ADR REPRESEN 0.6724% 0.6724% JOHNSON & JOHNSON 0.6151% 0.6151% TENCENT HOLDINGS LTD 0.6124% 0.6124% BERKSHIRE HATHAWAY INC CLASS B 0.5765% 0.5765% NESTLE SA 0.5428% 0.5428% VISA INC CLASS A 0.5408% 0.5408% PROCTER & GAMBLE 0.4838% 0.4838% JPMORGAN CHASE & CO 0.4730% 0.4730% UNITEDHEALTH GROUP INC 0.4619% 0.4619% ISHARES RUSSELL 3000 ETF 0.4525% 0.4525% HOME DEPOT INC 0.4463% 0.4463% TAIWAN SEMICONDUCTOR MANUFACTURING 0.4337% 0.4337% MASTERCARD INC CLASS A 0.4325% 0.4325% INTEL CORPORATION CORP 0.4207% 0.4207% SHORT-TERM INVESTMENT FUND 0.4158% 0.4158% ROCHE HOLDING PAR AG 0.4017% 0.4017% VERIZON COMMUNICATIONS INC 0.3792% 0.3792% NVIDIA CORP 0.3721% 0.3721% AT&T INC 0.3583% 0.3583% SAMSUNG ELECTRONICS LTD 0.3483% 0.3483% ADOBE INC 0.3473% 0.3473% PAYPAL HOLDINGS INC 0.3395% 0.3395% WALT DISNEY 0.3342% 0.3342% CISCO SYSTEMS INC 0.3283% 0.3283% MERCK & CO INC 0.3242% 0.3242% NETFLIX INC 0.3213% 0.3213% EXXON MOBIL CORP 0.3138% 0.3138% NOVARTIS AG 0.3084% 0.3084% BANK OF AMERICA CORP 0.3046% 0.3046% PEPSICO INC 0.3036% 0.3036% PFIZER INC 0.3020% 0.3020% COMCAST CORP CLASS A 0.2929% 0.2929% COCA-COLA 0.2872% 0.2872% ABBVIE INC 0.2870% 0.2870% CHEVRON CORP 0.2767% 0.2767% WALMART INC 0.2767% -
Fund to Retain Clinical Scientists to Bolster the Long-Term Careers of Young Physician Scientists
Kristin Roth-Schrefer, Communications Director [email protected] / 212.974.7003 Nina Chung, Communications Assistant [email protected] / 212.974.7006 Leslie Engel, Program Associate for Medical Research [email protected] / 212.974.7106 Ten Institutions Receive Grants Totaling $5.4 Million Through Inaugural Fund to Retain Clinical Scientists To Bolster the Long-term Careers of Young Physician Scientists NEW YORK, NY, December 3, 2015 – The Doris Duke Charitable Foundation today announced grants totaling $5.4 million to 10 medical schools to establish a Fund to Retain Clinical Scientists within each of their institutions. Each school will receive $540,000 over five years to provide stronger institutional support and supplemental funds for early-career physician scientists to maintain productivity during periods of excessive extraprofessional demands. DDCF launched the Fund to Retain Clinical Scientists (the Fund) to build upon a growing momentum in the medical research field toward supporting young physician scientists through phases of intense, extraprofessional career obstacles. Studies have revealed that up to 44 percent of young physicians with full-time faculty appointments at academic medical schools leave their posts within 10 years.1 Furthermore, while women enter academic medical centers at about the same rate as men, they make up only 19 percent of faculty at the full professor level.2 The causes of this disparity are varied and complex, but one contributing factor is the load of transitory but significant outside responsibilities such as childcare, elder care or family illness that may arise and preclude the career growth of many young faculty members, particularly women. “As a foundation committed to fostering the careers of physician scientists in academic medicine, we sought a way to retain promising early-career faculty during times they are most challenged by caregiving demands,” said Betsy Myers, program director for Medical Research. -
Ohio Stands Up! and Kristen Beckman, ) Plaintiffs, ) ) Attorneys: ) Thomas Renz (Bar ID 98645) ) 1907 W State St
IN THE UNITED STATES DISTRICT COURT WESTERN DIVISION FOR THE NORTHERN DISTRICT OF OHIO Ohio Stands Up! and Kristen Beckman, ) Plaintiffs, ) ) Attorneys: ) Thomas Renz (Bar ID 98645) ) 1907 W State St. #162 ) Fremont, OH 43420 ) ) CASE NO.: 3:20-cv-02814-JRK & ) ) Robert Gargasz (Bar ID 7136) ) 1670 Cooper Foster Park Rd. ) Lorain, OH 44053 ) ) & ) ) N. Ana Garner (NM Bar ID#921) ) 1000 Cordova Pl., #644 ) Santa Fe, NM 87505 ) (pending pro hac vice approval) ) ) -vs- ) JUDGE: James R. Knepp II ) The United States Department of Health & ) Human Services, Center for Disease Control ) (CDC), Secretary Norris Cochran, Director ) Rochelle Walensky, The National Center for ) Health Statistics (NCHS), Director Brian C. ) AMENDED COMPLAINT Moyer, and John and/or Jane Doe[s] 1-20, ) ) Defendants. ) Page 1 of 73 Table of Contents COMPLAINT: FEDERAL QUESTION ........................................................................................ 5 I. Introduction ............................................................................................................................. 5 II. Prayers for Relief .................................................................................................................... 7 III. Parties ................................................................................................................................... 8 A. Plaintiffs and Injury .......................................................................................................... 8 B. Defendants ..................................................................................................................... -
Boston San Francisco Munich London
Internet & Digital Media Monthly August 2018 BOB LOCKWOOD JERRY DARKO Managing Director Senior Vice President +1.617.624.7010 +1.415.616.8002 [email protected] [email protected] BOSTON SAN FRANCISCO HARALD MAEHRLE LAURA MADDISON Managing Director Senior Vice President +49.892.323.7720 +44.203.798.5600 [email protected] [email protected] MUNICH LONDON INVESTMENT BANKING Raymond James & Associates, Inc. member New York Stock Exchange/SIPC. Internet & Digital Media Monthly TECHNOLOGY & SERVICES INVESTMENT BANKING GROUP OVERVIEW Deep & Experienced Tech Team Business Model Coverage Internet / Digital Media + More Than 75 Investment Banking Professionals Globally Software / SaaS + 11 Senior Equity Research Technology-Enabled Solutions Analysts Transaction Processing + 7 Equity Capital Markets Professionals Data / Information Services Systems | Semiconductors | Hardware + 8 Global Offices BPO / IT Services Extensive Transaction Experience Domain Coverage Vertical Coverage Accounting / Financial B2B + More than 160 M&A and private placement transactions with an Digital Media Communications aggregate deal value of exceeding $25 billion since 2012 E-Commerce Consumer HCM Education / Non-Profit + More than 100 public equities transactions raising more than Marketing Tech / Services Financial $10 billion since 2012 Supply Chain Real Estate . Internet Equity Research: Top-Ranked Research Team Covering 25+ Companies . Software / Other Equity Research: 4 Analysts Covering 40+ Companies RAYMOND JAMES / INVESTMENT BANKING OVERVIEW . Full-service firm with investment banking, equity research, institutional sales & trading and asset management – Founded in 1962; public since 1983 (NYSE: RJF) – $6.4 billion in FY 2017 revenue; equity market capitalization of approximately $14.0 billion – Stable and well-capitalized platform; over 110 consecutive quarters of profitability . -
Banking Rewards & Dining
Banking Rewards & Dining: A Changing Landscape Presented by: Sponsored by: INTRODUCTION Banks and financial services companies have used Travel remains dining as a key differentiator for their card products the most impacted for many years. The COVID crisis has accelerated this category, still trend while upending existing usage of cards for other down over 50%... services. Simply put, during the pandemic, travel and Crisis fosters related benefits have become less relevant. Card issuers innovation. are pivoting to where consumers are spending instead, Vasant Prabhu namely: food. Vice Chairman and Chief Financial Officer, Visa Vasant Prabhu, Vice Chairman and CFO, of Visa, noted as much during a July earnings call, stating: “Travel remains the most impacted category, still down over 50%. Within the restaurant category, card-present spend is still declining, while card-not- present spend continues to grow significantly, with quick service restaurants outperforming.…Crisis fosters innovation. There’s a lot going on.”1 Card issuers are innovating. They are experimenting with differing approaches of how to adapt offerings to meet customers’ dining, delivery, and grocery needs during, as well as perhaps after, the pandemic. Background: dining and dining cards 2017 Dining cards have a long and rich heritage, starting Launch of Capital One Savor Card, with the launch of the Diners Club Card in 1950 by the first card catering to food spend businessman Frank McNamara. He founded the company following an incident: he forgot to bring his wallet to a New York restaurant and vowed never to be 2018 similarly embarrassed again.2 Citi Prestige increases earn for dining rewards to 5X points Over the past 5 years credit card companies have recognized dining as a key focus area to attract affluent consumers. -
As Physicians and Scientists Who Have Seen Firsthand the Value of U.S
January 31, 2017 The President The White House 1600 Pennsylvania Ave, NW Washington, DC, 20500 Dear Mr. President: As physicians and scientists who have seen firsthand the value of U.S. leadership in global health, we are writing to share our insights on the impacts of the investments this country has made and the vital importance of continuing them. The global health threats recently posed by influenza, Ebola and Zika make the increasing frequency and severity of transnational infectious disease outbreaks impossible to ignore. This pattern will continue. Addressing infectious diseases abroad is essential to protecting the American people at home and our economic interests abroad. The United States has been a longstanding leader in global health. Our country has been extraordinarily effective in improving the health of millions while advancing our global health security and strengthening our standing with international leaders and trade partners. We urge you to build on that leadership. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the most important and ambitious global health program ever implemented by any nation to address a single disease has had measurable impact on the lives of millions. PEPFAR supports lifesaving antiretroviral treatment for nearly 11.5 million people, has prevented two million babies from being born with HIV, and trained hundreds of thousands of health care workers in low-income countries. These remarkable achievements were made possible by the leadership and support of Administrations from both parties, by strong bipartisan Congressional support, and by scientific advances in HIV prevention and treatment developed through research supported by the National Institutes of Health.